SCHEMBL15401439

SCHEMBL15401439

CC(C)(CO)NC(=O)c1ncccc1C(N)=O

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.48
KDM4E B2RXH2 2/20 0.48
HPGD P15428 2/20 0.48
HSD17B10 Q99714 1/20 0.48
PDE10A Q9Y233 1/20 0.44
SMN1; SMN2 Q16637 5/20 0.44
MAPT P10636 3/20 0.44
RAB9A P51151 3/20 0.44
NPC1 O15118 2/20 0.44
AHR P35869 1/20 0.44
CNR2 P34972 6/20 0.43
CNR1 P21554 5/20 0.43
P2RX7 Q99572 1/20 0.43
PARP1 P09874 1/20 0.41
SYK P43405 1/20 0.40
HTT P42858 1/20 0.40
LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15401441 0.83 GRM4 (0.46) PDE10ARAB9ANPC1CNR2CNR1
SCHEMBL13962868 0.81 CNR2 (0.46) PDE10ARAB9ANPC1CNR2CNR1
SCHEMBL6415759 0.80 CNR2 (0.47) PDE10ACNR2CNR1
SCHEMBL28841192 0.80 PARP1 (0.49) ALDH1A1KDM4EHPGDHSD17B10SMN1; SMN2
SCHEMBL7459945 0.78 KDM4E (0.48) ALDH1A1KDM4EHPGDHSD17B10PDE10A
SCHEMBL7452418 0.77 KDM4E (0.49) ALDH1A1KDM4EHPGDHSD17B10SMN1; SMN2
SCHEMBL9736861 0.77 SMN1; SMN2 (0.50) ALDH1A1HPGDSMN1; SMN2NPC1CNR2
SCHEMBL7452205 0.77 KDM4E (0.52) ALDH1A1KDM4EHPGDHSD17B10SMN1; SMN2
SCHEMBL5902495 0.76 PARP1 (0.50) ALDH1A1KDM4EHPGDHSD17B10SMN1; SMN2
SCHEMBL15402857 0.75 KDM4E (0.48) ALDH1A1KDM4EHPGDHSD17B10PDE10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2580207-B1 NITROGEN CONTAINING HETEROARYL COMPOUNDS HOFFMANN LA ROCHE (CH) 2017-09-27 EP claimed
US-8703768-B2 Nitrogen containing heteroaryl compounds HOFFMANN-LA ROCHE INC. (US) 2014-04-22 US claimed
US-8623866-B2 2014-01-07 US claimed
US-20110306589-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2011-12-15 US claimed
EP-2580207-B1 NITROGEN CONTAINING HETEROARYL COMPOUNDS HOFFMANN LA ROCHE (CH) 2017-09-27 EP disclosed
US-8703768-B2 Nitrogen containing heteroaryl compounds HOFFMANN-LA ROCHE INC. (US) 2014-04-22 US disclosed
US-8623866-B2 2014-01-07 US disclosed
US-20110306589-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2011-12-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110306589-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS PDE10A, PDE3A, PDE2A ALDH1A1 271/4885KDM4E 2322/4885HPGD 603/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.